Background: Adolescence is considered as a critical time period in multiple sclerosis (MS) etiology. Nonetheless, there are insufficient reports regarding the potential role of fresh and canned fish consumptions during adolescence in MS etiology. The authors investigated the association between fresh and canned fish consumptions and MS. Methods: This was a population-based incident case-control study conducted in Tehran. Cases (n = 547) identified from Iranian Multiple Sclerosis Society between August 7, 2013, and November 17, 2015 were included in the study. Population-based controls (n = 1,057) were recruited by random digit telephone dialing without any matching. Inverse-probability-of-treatment weighing (IPTW) using 2 sets of propensity scores and model-based standardization were used to separately estimate the marginal odds ratio between fresh and canned fish consumptions in adolescence and MS. Results: The marginal OR for fresh fish was 0.72 (95% CI 0.58–0.90; p = 0.005) in both IPTW analyses. Similarly, the marginal OR for canned fish consumption was 0.75 (95% CI 0.60–0.95; p = 0.014).The model-based standardized OR was 0.72 (95% CI 0.58–0.91; p = 0.008) for fresh and 0.73 (95% CI 0.59–0.94; p = 0.006) for canned fish consumption in adolescence. Discussion: Subject to limitation of case-control studies in interpreting associations causally, this study suggests that both fresh and canned fish consumptions in adolescence can decrease the risk of MS.

Keywords:
Causal analysis, Case-control study, Inverse-probability-of-treatment weighting, Model-based standardization, Multiple sclerosis, Fish intake
1.
Browne P, Chandraratna D, Angood C, Tremlett H, Baker C, Taylor BV, Thompson AJ: Atlas of multiple Sclerosis 2013: a growing global problem with widespread inequity. Neurology 2014; 83: 1022–1024.
2.
Elhami SR, Mohammad K, Sahraian MA, Eftekhar H: A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study. Neuroepidemiology 2011; 36: 141–147.
3.
Etemadifar M, Maghzi AH: Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran. Mult Scler 2011; 17: 1022–1027.
4.
Abdollahpour I, Nedjat S, Sahraian MA, Mansournia MA, Otahal P, van der Mei I: Waterpipe smoking associated with multiple sclerosis: a population-based incident case-control study. Mult Scler: 2017; 23: 1328–1335.
5.
Hedström AK, Bäärnhielm M, Olsson T, Alfredsson L: Exposure to environmental tobacco smoke is associated with increased risk for multiple sclerosis. Mult Scler 2011; 17: 788–793.
6.
Handel AE, Williamson AJ, Disanto G, Dobson R, Giovannoni G, Ramagopalan SV: Smoking and multiple sclerosis: an updated meta-analysis. PLoS One 2011; 6:e16149.
7.
Munger KL, Zhang SM, O'Reilly E, Hernan MA, Olek MJ, Willett WC, Ascherio A: Vitamin D intake and incidence of multiple sclerosis. Neurology 2004; 62: 60–65.
8.
Mansournia MA, Danaei G, Forouzanfar MH, Mahmoodi M, Jamali M, Mansournia N, Mohammad K: Effect of physical activity on functional performance and knee pain in patients with osteoarthritis: analysis with marginal structural models. Epidemiology 2012; 23: 631–640.
9.
Rothman KJ, Greenland S, Lash TL: Modern Epidemiology. Philadelphia, Lippincott Williams & Wilkins, 2008.
10.
Rose S, van der Laan M: A double robust approach to causal effects in case-control studies. Am J Epidemiol 2014; 179: 663–669.
11.
Newman SC: Causal analysis of case-control data. Epidemiol Perspect Innovs 2006; 27: 2.
12.
Mannsson R, Joffe MM, Sun W, Hennessy S: On the estimation and use of propensity scores in case-control and case-cohort studies. Am J Epidemiol 2007; 166: 332–339.
13.
Mansournia MA, Etminan M, Danaei G, Kaufman JS, Collins G: Handling time varying confounding in observational research. BMJ 2017; 359:j4587.
14.
Gharibzadeh S, Mohammad K, Rahimiforoushani A, Amouzegar A, Mansournia MA: Standardization as a tool for causal inference in medical research. Arch Iran Med. 2016; 19: 666–670.
15.
Heydarpour P, Mohammad K, Yekaninejad MS, Elhami SR, Khoshkish S, Sahraian MA: Multiple sclerosis in Tehran, Iran: a joinpoint trend analysis. Mult Scler 2013; 20: 512.
16.
Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L: Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292–302.
17.
Wacholder S, Silverman DT, McLaughlin JK, Mandel JS: Selection of controls in case-control studies. II. Types of controls. Am J Epidemiol 1992; 135: 1029–1041.
18.
Clagett B, Nathanson KL, Ciosek SL, McDermoth M, Vaughn DJ, Mitra N, Weiss A, Martonik R, Kanetsky PA: Comparison of address-based sampling and random-digit dialing methods for recruiting young men as controls in a case-control study of testicular cancer susceptibility. Am J Epidemiol 2013; 178: 1638–1647.
19.
Gundersen DA, ZuWallack RS, Dayton J, Echeverría SE, Delnevo CD: Assessing the feasibility and sample quality of a national random-digit dialing cellular phone survey of young adults. Am J Epidemiol 2014; 179: 39–47.
20.
Kish L: A procedure for objective respondent selection within the household. Journal of the American Statistical Association 1949; 44: 380–387.
21.
Binson D, Canchola JA, Catania JA: Random selection in a national telephone survey: a comparison of the Kish, next-birthday, and last-birthday methods. J Official Stat Stockh 2000; 16: 53–60.
22.
Pugliatti M, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Myhr KM, Parpinel M, Pekmezovic T, Riise T, Zhu B, Wolfson C: A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q). Acta Neurol Scand Suppl 2012; 195: 43–50.
23.
Feskanich D, Rimm EB, Giovannucci EL, Colditz GA, Stampfer MJ, Litin LB, Willett WC: Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc 1993; 93: 790–796.
24.
Greenland S, Pearl J, Robins JM: Causal diagrams for epidemiologic research. Epidemiology 1999; 10: 37–48.
25.
Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P: International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003; 195: 3508–1381.
26.
Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, O’Brien WL, Bassett DR, Schmitz KH, Emplaincourt PO: Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000; 32(suppl 9):S498–S504.
27.
Strong WB, Malina RM, Blimkie CJ, Daniels SR, Dishman RK, Gutin B, Hergenroeder AC, Must A, Nixon PA, Pivarnik JM, Rowland T, Trost S, Trudeau F: Evidence based physical activity for school-age youth. J Pediatr 2005; 146: 732–737.
28.
Adler NE, Epel ES, Castellazzo G, Ickovics JR: Relationship of subjective and objective social status with psychological and physiological functioning: preliminary data in healthy white women. Health psychol 2000; 19: 586–592.
29.
Mansournia MA, Altman DG: Inverse probability weighting. BMJ 2016; 352:i189.
30.
Månsson R, Joffe MM, Sun W, Hennessy S: On the estimation and use of propensity scores in case-control and case-cohort studies. Am J Epidemiol 2007; 166: 332–339.
31.
Elhami SR, Mohammad K, Sahraian MA, Eftekhar H: A 20-year incidence trend (1989–2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study. Neuroepidemiology 2010; 36: 141–147.
32.
Rubin DB: Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997; 127: 757–763.
33.
Rubin DB, Thomas N: Matching using estimated propensity scores: relating theory to practice. Biometrics 1996; 52: 249–264.
34.
Robins J: A new approach to causal inference in mortality studies with a sustained exposure period – application to control of the healthy worker survivor effect. Mathematical Modelling 1986; 7: 1393–1512.
35.
Austin PC: The relative ability of different propensity score methods to balance measured covariates between treated and untreated subjects in observational studies. Med Decis Making 2009; 29: 661–677.
36.
Calder PC: n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006; 83(suppl 6):1505S–1519S.
37.
Brookhart MA, Schneeweiss S, Rothman KJ, Glynn RJ, Avorn J, Stürmer T: Variable selection for propensity score models. Am J Epidemiol 2006; 163: 1149–1156.
38.
Nimptsch K, Bernstein AM, Giovannucci E, Fuchs CS, Willett WC, Wu K: Dietary intakes of red meat, poultry, and fish during high school and risk of colorectal adenomas in women. Am J Epidemiol 2013; 178: 172–183.
39.
Maruti SS, Feskanich D, Colditz GA, Frazier AL, Sampson LA, Michels KB, Hunter DJ, Spiegelman D, Willett WC: Adult recall of adolescent diet: reproducibility and comparison with maternal reporting. Am J Epidemiol 2005; 161: 89–97.
40.
Chavarro JE, Michels KB, Isaq S, Rosner BA, Sampson L, Willey C, Tocco P, Willett WC, Chumlea WC: Validity of maternal recall of preschool diet after 43 years. Am J Epidemiol 2009; 169: 1148–1157.
41.
Massey JT, O’Connor D, Krotki K: Response Rates in Random Digit Dialing (RDD) Telephone Surveys: Proceedings of the American Statistical Association, Section on Survey Research Methods, 1997, pp 707–712.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.